News
Eutelsat Communications: First Quarter 2022-23 Revenues
Regulatory News:
Eutelsat Communications (ISIN: FR0010221234 - Euronext Paris: ETL) reports revenues for the First Quarter ended 30 September 2022.
In € millions
Q1 2021-22
Q1
Eutelsat Strategy Update on the Proposed Combination with OneWeb
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221011006201/en/
Eutelsat Communications (Euronext Paris: ETL) today
Poxel to Present DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix beim Gartner® Hype Cycle™ für Anwendungssicherheit 2022 als „Sample Vendor“ ausgezeichnet
Verimatrix, (Euronext Paris: VMX) (Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen im Bericht
SISM Investors stuft Condor Technologies NV mit Buy-Rating ein
Ernest C. Schlotter, Senior Analyst bei SISM Investors mit Sitz in Zürich, Schweiz, und laut StarMine, einem ehemals zu Thomson Reuters gehörenden Unternehmen, ein Vier-Sterne-Analyst
Verimatrix Recognized as a Sample Vendor in 2022 Gartner® Hype Cycle™ for Application Security
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it has been identified as a Sample
EQS-News: Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis
SISM Investors Initiates Coverage on Condor Technologies NV With a Buy Rating
Ernest C. Schlotter, a senior analyst at SISM Investors based in Zurich, Switzerland, and a four-star analyst according to StarMine, a former Thomson Reuters company, published an eight-page report
Nanobiotix: Voting Rights and Shares Capital of the Company
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
BIOCORP und Merck KGaA, Darmstadt, Deutschland, schließen neue Partnerschaft für intelligente Arzneimittelverabreichung
BIOCORP (FR0012788065 – ALCOR / PEA/KMU-qualifiziert) (Paris:ALCOR), ein französisches Unternehmen, das auf die Konzeption, Entwicklung und Herstellung innovativer medizinischer Geräte
BIOCORP and Merck KGaA, Darmstadt, Germany, Sign a New Partnership for Smart Drug Delivery
Regulatory News:
BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, and
Valbiotis Accelerates Its Marketing Strategy
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and
Valbiotis forciert seine Marketingstrategie
Valbiotis (FR0013254851 – ALVAL, PEA / SME förderfähig), ein Unternehmen für Forschung und Entwicklung, das sich der wissenschaftlichen Innovation zur Vorbeugung und Bekämpfung von Stoffwechsel-
Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
PATRIMOINE ET COMMERCE: Q3 2022 RESULTS +7,3% IN GROSS RENTAL INCOME AT €35.3M
Availability of Poxel's 2022 Half-Year Financial Report
POXEL SA (Euronext: POXEL - FR0012432516), a clinical-stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
BILENDI: Very strong growth in results for H1 2022
UV GERMI chosen by EPUR (Veolia) to equip its new dedicated wastewater reuse units
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
Regulatory News:
Median Technologies (Paris:ALMDT) announced today the formation of their Clinical Advisory Board (CAB) for iBiopsy® Lung Cancer Screening. This group of world class physicians
Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF THE 2022 BUSINESS YEAR
EQS-News: ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022
Pharnext announces a reverse stock split and suspension of the right to exercise all the securities giving access to Pharnext's share capital including the conversions of convertible bonds
Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A
RUBIS: Information relating to the total number of voting rights and shares as of 30/09/2022